Published in PLoS One on June 05, 2015
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol (2013) 18.01
Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature (2004) 16.56
Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development (2002) 12.21
Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem (1999) 10.14
Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun (1997) 7.87
Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection. Nat Methods (2011) 6.90
Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell (1999) 6.53
An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat Biotechnol (2011) 6.44
Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. Development (2000) 5.30
beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev (1998) 5.25
Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc Natl Acad Sci U S A (2001) 4.51
Transgenic mice with green fluorescent protein-labeled pancreatic beta -cells. Am J Physiol Endocrinol Metab (2002) 4.45
CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res (2013) 4.11
Similarities and differences among 105 members of the Int family of site-specific recombinases. Nucleic Acids Res (1998) 3.71
Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol Cell (2001) 3.43
Conditional gene targeting in mouse pancreatic ß-Cells: analysis of ectopic Cre transgene expression in the brain. Diabetes (2010) 2.80
In vitro proliferation of cells derived from adult human beta-cells revealed by cell-lineage tracing. Diabetes (2008) 2.64
Efficient targeted gene disruption in Xenopus embryos using engineered transcription activator-like effector nucleases (TALENs). Proc Natl Acad Sci U S A (2012) 2.53
RIP-Cre revisited, evidence for impairments of pancreatic beta-cell function. J Biol Chem (2005) 2.32
Neurogenin3 delineates the earliest stages of spermatogenesis in the mouse testis. Dev Biol (2004) 2.13
Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metab (2012) 2.04
Tie-1-directed expression of Cre recombinase in endothelial cells of embryoid bodies and transgenic mice. J Cell Sci (2001) 1.67
Extrapancreatic insulin-producing cells in multiple organs in diabetes. Proc Natl Acad Sci U S A (2004) 1.67
Broad specificity profiling of TALENs results in engineered nucleases with improved DNA-cleavage specificity. Nat Methods (2014) 1.66
Comparative analysis of insulin gene promoters: implications for diabetes research. Diabetes (2006) 1.65
Pancreas-specific Cre driver lines and considerations for their prudent use. Cell Metab (2013) 1.45
Brain insulin: regulation, mechanisms of action and functions. Cell Mol Neurobiol (2003) 1.42
Orchestrating transcriptional control of adult neurogenesis. Genes Dev (2012) 1.41
Mosaic Cre-mediated recombination in pancreas using the pdx-1 enhancer/promoter. Genesis (2000) 1.37
Cryptic loxP sites in mammalian genomes: genome-wide distribution and relevance for the efficiency of BAC/PAC recombineering techniques. Nucleic Acids Res (2007) 1.20
Tamoxifen-independent recombination in the RIP-CreER mouse. PLoS One (2010) 1.12
A single vector containing modified cre recombinase and LOX recombination sequences for inducible tissue-specific amplification of gene expression. Nucleic Acids Res (2001) 1.07
Brain expression of Cre recombinase driven by pancreas-specific promoters. Genesis (2010) 1.06
Comprehensive analysis of the specificity of transcription activator-like effector nucleases. Nucleic Acids Res (2014) 1.04
Requirements for catalysis in the Cre recombinase active site. Nucleic Acids Res (2010) 0.98
Promoter interference mediated by the U3 region in early-generation HIV-1-derived lentivirus vectors can influence detection of transgene expression in a cell-type and species-specific manner. Hum Gene Ther (2003) 0.97
Knock-in of diphteria toxin A chain gene at Ins2 locus: effects on islet development and localization of Ins2 expression in the brain. Transgenic Res (2004) 0.96
Transcription factors in pancreatic development. Animal models. Endocr Dev (2007) 0.93
Generation and characterization of Ins1-cre-driver C57BL/6N for exclusive pancreatic beta cell-specific Cre-loxP recombination. Exp Anim (2014) 0.90
Intra-arterial targeted islet-specific expression of Sirt1 protects β cells from streptozotocin-induced apoptosis in mice. Mol Ther (2010) 0.89
Cerebellar defects in Pdss2 conditional knockout mice during embryonic development and in adulthood. Neurobiol Dis (2011) 0.88
The chicken hypersensitivity site 4 core insulator blocks promoter interference in lentiviral vectors. Hum Gene Ther Methods (2013) 0.83
The insulin regulatory network in adult hippocampus and pancreatic endocrine system. Stem Cells Int (2012) 0.81
Pancreatic cells and their progenitors. Methods Enzymol (2006) 0.80
Development of a novel beta-cell specific promoter system for the identification of insulin-producing cells in in vitro cell cultures. Exp Cell Res (2006) 0.80
Genetic lineage tracing of beta cell neogenesis. Methods Mol Biol (2012) 0.78
Alterations of pancreatic beta-cell mass and islet number due to Ins2-controlled expression of Cre recombinase: RIP-Cre revisited; part 2. Horm Metab Res (2007) 0.78
A practical guide to genetic engineering of pancreatic β-cells in vivo: getting a grip on RIP and MIP. Islets (2014) 0.76